兔抗NAA10多克隆抗體

Background:

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants.

Applications:

ELISA, WB, IHC

Name of antibody:

NAA10

Immunogen:

Fusion protein of human NAA10

Full name:

N(alpha)-acetyltransferase 10, NatA catalytic subunit

Synonyms:

TE2; ARD1; NATD; ARD1A; ARD1P; OGDNS; hARD1; DXS707; MCOPS1

SwissProt:

P41227

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human tonsil and Human thyroid cancer

IHC Recommend dilution:

50-300

WB Predicted band size:

26 kDa

WB Positive control:

Hela and 293T cell lysates

WB Recommended dilution:

200-1000